Indications
Treatment of opioid-induced constipation in advanced-illness patients who are receiving palliative care when response to usual laxative therapy has not been sufficient.
Composition
- Active substance
- methylnaltrexone bromide
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Relistor
- Active substance
- methylnaltrexone bromide
- ATC code
- A06AH01
- Therapeutic area
- Opioid-Related Disorders, Constipation
- Marketing authorisation holder
- Bausch Health Ireland Limited
- Status
- Authorised